Abstract
After 25 years of intensive research, the understanding of how photoreceptors in the eye perceive light and convert it into nerve signals has largely advanced. Central to this is the structural and mechanistic exploration of the G protein-coupled receptor rhodopsin acting as a dim-light sensing pigment in the retina. Investigation of rhodopsin by X-ray crystallographic, electron microscopic, and biochemical means depends on the ability to produce and isolate pure rhodopsin protein. Robust and well-defined protocols permit the production and crystallization of rhodopsin variants to investigate the inactive ground, the fully activated metarhodopsin II state, or disease-causing rhodopsin mutations. This chapter details how we express and purify biologically active variants of rhodopsin from HEK293S GnTI− cells in a quality and quantity suitable for biochemical assays, crystallization, and structure determination.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Palczewski K (2012) Chemistry and biology of vision. J Biol Chem 287:1612–1619
Palczewski K, Kumasaka T, Hori T et al (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289:739–745
Li J, Edwards PC, Burghammer M et al (2004) Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol 343:1409–1438
Nakamichi H, Okada T (2006) Local peptide movement in the photoreaction intermediate of rhodopsin. Proc Natl Acad Sci U S A 103:12729–12734
Nakamichi H, Okada T (2006) Crystallographic analysis of primary visual photochemistry. Angew Chem Int Ed Engl 45:4270–4273
Salom D, Lodowski DT, Stenkamp RE et al (2006) Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc Natl Acad Sci U S A 103:16123–16128
Choe HW, Kim YJ, Park JH et al (2011) Crystal structure of metarhodopsin II. Nature 471:651–655
Park JH, Scheerer P, Hofmann KP et al (2008) Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454:183–187
Edwards PC, Li J, Burghammer M et al (2004) Crystals of native and modified bovine rhodopsins and their heavy atom derivatives. J Mol Biol 343:1439–1450
Okada T, Le Trong I, Fox BA et al (2000) X-Ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. J Struct Biol 130:73–80
Xie G, Gross AK, Oprian DD (2003) An opsin mutant with increased thermal stability. Biochemistry 42:1995–2001
Standfuss J, Xie G, Edwards PC et al (2007) Crystal structure of a thermally stable rhodopsin mutant. J Mol Biol 372:1179–1188
Deupi X, Edwards P, Singhal A et al (2012) Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II. Proc Natl Acad Sci U S A 109:119–124
Standfuss J, Edwards PC, D'Antona A et al (2011) The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature 471:656–660
Singhal A, Ostermaier MK, Vishnivetskiy SA et al (2013) Insights into congenital stationary night blindness based on the structure of G90D rhodopsin. EMBO Rep 14:520–526
Reeves PJ, Callewaert N, Contreras R et al (2002) Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc Natl Acad Sci U S A 99:13419–13424
Reeves PJ, Kim JM, Khorana HG (2002) Structure and function in rhodopsin: a tetracycline-inducible system in stable mammalian cell lines for high-level expression of opsin mutants. Proc Natl Acad Sci U S A 99:13413–13418
Molday RS, MacKenzie D (1983) Monoclonal antibodies to rhodopsin: characterization, cross-reactivity, and application as structural probes. Biochemistry 22:653–660
Maeda S, Sun D, Singhal A et al (2014) Crystallization scale preparation of a stable GPCR signaling complex between constitutively active rhodopsin and G-protein. PloS One 9:e98714
Krebs MP, Holden DC, Joshi P et al (2010) Molecular mechanisms of rhodopsin retinitis pigmentosa and the efficacy of pharmacological rescue. J Mol Biol 395:1063–1078
Chaudhary S, Pak JE, Pedersen BP et al (2011) Efficient expression screening of human membrane proteins in transiently transfected human embryonic kidney 293S cells. Methods 55:273–280
Standfuss J, Zaitseva E, Mahalingam M et al (2008) Structural impact of the E113Q counterion mutation on the activation and deactivation pathways of the G protein-coupled receptor rhodopsin. J Mol Biol 380:145–157
Chaudhary S, Pak JE, Gruswitz F et al (2012) Overexpressing human membrane proteins in stably transfected and clonal human embryonic kidney 293S cells. Nat Protoc 7:453–466
Acknowledgments
We thank Marcello Foggetta, Martin Siegrist, and Agnese Baronina for technical assistances and valuable discussions. We are grateful for the financial support from the Roche Postdoctoral Research Fellowship RPF298 (to D.M.) and from the Swiss National Science Foundation (SNSF) grant 31003A_141235 (to J.S.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Mattle, D., Singhal, A., Schmid, G., Dawson, R., Standfuss, J. (2015). Mammalian Expression, Purification, and Crystallization of Rhodopsin Variants. In: Jastrzebska, B. (eds) Rhodopsin. Methods in Molecular Biology, vol 1271. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2330-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2330-4_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2329-8
Online ISBN: 978-1-4939-2330-4
eBook Packages: Springer Protocols